We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.94B
AUM Growth
-$464M
Cap. Flow
-$553M
Cap. Flow %
-18.83%
Top 10 Hldgs %
35.63%
Holding
94
New
11
Increased
10
Reduced
24
Closed
23

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
3
IRTC icon
iRhythm Holdings
IRTC
+$48.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$38.4M
5
CAH icon
Cardinal Health
CAH
+$31.4M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$57.5M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$51.2M
3
HCA icon
HCA Healthcare
HCA
+$47.7M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$43.2M
5
GILD icon
Gilead Sciences
GILD
+$40.6M

Sector Composition

Rank Sector Weight
1 Healthcare 94.07%
2 Financials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CERT icon
76
Certara
CERT
$1.25B
– –
-143,028
Closed -$4.73M
DVAX
77
CALL
DELISTED
Dynavax Technologies
DVAX
– –
-521,800
Closed -$10M
GH icon
78
Guardant Health
GH
$21.9B
– –
-84,455
Closed -$10.6M
GILD icon
79
CALL
Gilead Sciences
GILD
$164B
– –
-963,700
Closed -$67.3M
HUM icon
80
CALL
Humana
HUM
$43.7B
– –
-21,000
Closed -$8.17M
LFST icon
81
Lifestance Health
LFST
$3.96B
– –
-443,595
Closed -$6.43M
NBIX icon
82
CALL
Neurocrine Biosciences
NBIX
$16.4B
– –
-261,500
Closed -$25.1M
SGHT icon
83
Sight Sciences
SGHT
$302M
– –
-483,538
Closed -$11M
SPRY icon
84
ARS Pharmaceuticals
SPRY
$532M
– –
-188,243
Closed -$1.88M
STVN icon
85
Stevanato
STVN
$5.49B
– –
-549,002
Closed -$13.9M
UNH icon
86
CALL
UnitedHealth
UNH
$375B
– –
-157,200
Closed -$61.4M
XLF icon
87
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.6B
– –
-1,602,200
Closed -$60.1M
ZLAB icon
88
Zai Lab
ZLAB
$2.07B
– –
-99,375
Closed -$10.5M
DCPH
89
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-143,297
Closed -$4.87M
MRTX
90
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-15,000
Closed -$2.65M
VECT
91
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
– –
-544,706
Closed -$4.21M
HZNP
92
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-439,400
Closed -$48.1M
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

PFM Health Sciences's Q4 2021 Portfolio in Review

As of Q4 2021, PFM Health Sciences held 94 positions worth $2.94B, down 14% from $3.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

PFM Health Sciences withdrew a net $553M in Q4 2021, closing 23 positions and reducing 24 holdings. Its most notable exit was Allogene Therapeutics, an estimated $19.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 86% a quarter earlier, followed by Financials.

Against the trend, PFM Health Sciences opened a new position in Pfizer worth $79.3M.

  • PFM Health Sciences's largest Q4 2021 buy was Pfizer: 1,343,384 shares worth $79.3M.
  • PFM Health Sciences added most to CATALENT, INC. in Q4 2021, an estimated $19.1M increase.
  • PFM Health Sciences's biggest Q4 2021 reduction was Eli Lilly, cutting an estimated $57.5M.
  • PFM Health Sciences fully exited Allogene Therapeutics in Q4 2021, selling an estimated $19.9M.
  • PFM Health Sciences's ten largest holdings make up 36% of its $2.94B portfolio in Q4 2021.
  • PFM Health Sciences opened 11 new positions and closed 23 in Q4 2021.
  • PFM Health Sciences's portfolio value fell 14% quarter-over-quarter to $2.94B.

Based on PFM Health Sciences's 13F filing for Q4 2021, filed 14 Feb 2022.